On 25 September, President of Latvia Edgars Rinkēvičs in San Diego, California, USA, met with the management of biotech company Element Biosciences.
During the meeting, the President of Latvia expressed Latvia's interest engage in joint research and development projects with US counterparts, and also the involvement of Latvian scientists and doctors in the development of new technologies, and, prospectively, also in US companies. “Latvia is a competitive place in Europe where a US company can cooperate with Latvian researchers and doctors in developing and testing new genomics solutions, while also making use of Latvia's connection to the wider European research area,” President Rinkēvičs said.
Also during the meeting, a memorandum of understanding was signed between the National Research and Innovation Institute — the principal institution in Latvia responsible for maintaining the national biobank and the state's genomics infrastructure — and Element Biosciences.
